H19 and adenomyosis: In fibroids, H19 overexpression drives ECM accumulation via TGF-β and collagen regulation [20], whereas in adenomyosis, H19 acts primarily through inflammatory derepression (via miR-17 → TLR4/NF-κB) [59].